发明公开
- 专利标题： THERAPEUTIC USE OF A TLR AGONIST AND COMBINATION THERAPY
- 专利标题（中）： TLR激动剂和联合治疗的治疗应用
-
申请号： EP16199830.7申请日： 2011-10-03
-
公开(公告)号： EP3195868A3公开(公告)日： 2017-08-02
- 发明人: HERSHBERG, Robert , COUKOS, George , DIETSCH, Gregory , FACCIABENE, Andrea , MANJARREZ, Kristi , RANDALL, Tressa D.
- 申请人： VentiRx Pharmaceuticals, Inc. , The Trustees of the University of Pennsylvania
- 申请人地址： 1191 Second Avenue, Suite 1105 Seattle, WA 98101 US
- 专利权人： VentiRx Pharmaceuticals, Inc.,The Trustees of the University of Pennsylvania
- 当前专利权人： VentiRx Pharmaceuticals, Inc.,The Trustees of the University of Pennsylvania
- 当前专利权人地址： 1191 Second Avenue, Suite 1105 Seattle, WA 98101 US
- 代理机构： Cooley (UK) LLP
- 优先权： US388967P 20101001; US388953P 20101001; US390447P 20101006
- 主分类号： A61K31/55
- IPC分类号： A61K31/55 ; A61K31/122 ; A61K9/127 ; A61K9/48 ; A61P35/00 ; A61K31/704 ; A61K31/7068 ; A61K9/00 ; A61K31/675 ; A61K45/06
摘要：
The present invention is directed generally to formulations of a TLR agonist preferably a TLR8 agonist, and its use in the treatment of various diseases, including combination therapies for treating cancer.
公开/授权文献
- EP3195868A2 THERAPEUTIC USE OF A TLR AGONIST AND COMBINATION THERAPY 公开/授权日：2017-07-26
信息查询
